FDIV - ETF AI Analysis
Top Page
MarketDesk Focused U.S. Dividend ETF (FDIV)
Rating:69Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The fund spreads its investments across several sectors like financials, industrials, consumer stocks, technology, and health care, which helps reduce the impact if any one area of the market struggles.
Generally Positive Recent Performance
The ETF has shown overall positive returns so far this year and over the past month, suggesting its strategy has been working reasonably well in the current market.
Multiple Strong Individual Holdings
Several top positions, such as Columbia Sportswear, Emerson Electric, Rockwell Automation, and UnitedHealth, have delivered strong gains, supporting the fund’s overall results.
Negative Factors
Meaningful Exposure to Weak Holdings
Some of the larger positions, including Jefferies, Blackstone, ADT, Synchrony Financial, and CRH, have shown weak or negative performance, which can drag on the ETF’s returns.
Heavy Tilt Toward U.S. Market
With almost all assets invested in U.S. companies and only a small slice abroad, the fund is highly dependent on the health of the U.S. economy and stock market.
Moderate Expense Ratio
The fund’s expense ratio is not especially low, meaning fees take a noticeable, though not extreme, bite out of long-term returns compared with the cheapest ETFs.
FDIV vs. SPDR S&P 500 ETF (SPY)
AUM72.39M
RegionNorth America
Expense Ratio0.35%
Beta0.57
IssuerMarketDesk
Inception DateSep 19, 2023
Dividend Yield2.4%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,334
30 Day Avg. Volume11,466
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.98Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering62
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FDIV Summary
The MarketDesk Focused U.S. Dividend ETF (FDIV) is an exchange-traded fund that invests mainly in U.S. companies that pay relatively high dividends, aiming to provide steady income plus some growth. It does not track a specific index, but instead follows a high-dividend theme across many sectors like financials, industrials, and consumer companies. Well-known holdings include UnitedHealth and Blackstone. Someone might invest in FDIV to diversify their portfolio while earning regular dividend payments. A key risk is that stock prices and dividend payments can go up or down with the market, so your investment value is not guaranteed.
How much will it cost me?The MarketDesk Focused U.S. Dividend ETF (FDIV) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on selecting high-yield dividend-paying U.S. companies rather than tracking a passive index.
What would affect this ETF?The FDIV ETF, focused on high-yield dividend-paying U.S. companies, could benefit from stable economic conditions and increased investor interest in dividend income during periods of market uncertainty. However, it may face challenges if interest rates rise, as higher rates can make bonds more attractive compared to dividend stocks, or if sector-specific issues impact key areas like Consumer Defensive or Health Care, which have significant weight in the portfolio.
FDIV Top 10 Holdings
FDIV leans heavily on U.S. financials, with names like Citigroup and Goldman Sachs doing much of the heavy lifting as their shares have been steadily rising and helping drive the fund’s recent gains. Williams-Sonoma has also been a bright spot, adding a bit of consumer flair to the income mix. On the flip side, Axis Capital has been lagging and Sysco looks a bit wobbly lately, modestly tugging on performance. Overall, this is a U.S.-only, dividend-focused portfolio with a clear tilt toward banks and insurers.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Millicom International Cellular SA | 2.20% | $1.60M | $16.04B | 152.40% | 71 Outperform | |
| Allstate | 2.20% | $1.59M | $66.02B | 30.10% | 74 Outperform | |
| Elevance Health | 2.19% | $1.59M | $92.33B | 26.94% | 76 Outperform | |
| Axis Capital | 2.18% | $1.58M | $8.44B | 17.23% | 70 Neutral | |
| Yum! Brands | 2.14% | $1.55M | $44.56B | 9.09% | 59 Neutral | |
| Waste Management | 2.13% | $1.54M | $95.06B | 3.73% | 76 Outperform | |
| MSC Industrial | 2.12% | $1.53M | $6.92B | 40.27% | 68 Neutral | |
| T Rowe Price | 2.11% | $1.53M | $24.35B | 15.34% | 75 Outperform | |
| Johnson & Johnson | 2.10% | $1.52M | $620.51B | 63.59% | 78 Outperform | |
| Eversource Energy | 2.09% | $1.51M | $28.15B | 15.33% | 66 Neutral |
FDIV Technical Analysis
Positive
―
Price Trends
27.50
Positive
27.43
Positive
27.10
Positive
Market Momentum
0.07
Positive
47.26
Neutral
13.62
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDIV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.85, equal to the 50-day MA of 27.50, and equal to the 200-day MA of 27.10, indicating a neutral trend. The MACD of 0.07 indicates Positive momentum. The RSI at 47.26 is Neutral, neither overbought nor oversold. The STOCH value of 13.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FDIV.
FDIV Peer Comparison
Comparison Results
Performance Comparison
FDIV
MarketDesk Focused U.S. Dividend ETF
27.63
1.75
6.76%
PAYR
Federated Hermes Enhanced Income ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VUS
Virtus US Dividend ETF
―
―
―
JHDV
John Hancock U.S. High Dividend ETF
―
―
―
DDDD
YieldMax U.S. Stocks Target Double Distribution ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents